These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18034766)

  • 1. Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A.
    Hvas AM; Sørensen HT; Norengaard L; Christiansen K; Ingerslev J; Sørensen B
    J Thromb Haemost; 2007 Dec; 5(12):2408-14. PubMed ID: 18034766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents.
    Stagaard R; Flick MJ; Bojko B; Goryński K; Goryńska PZ; Ley CD; Olsen LH; Knudsen T
    J Thromb Haemost; 2018 Jul; 16(7):1369-1382. PubMed ID: 29758126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.
    Rea CJ; Foley JH; Bevan DH; Sørensen B
    Ann Hematol; 2014 Apr; 93(4):683-92. PubMed ID: 24193375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study.
    Janbain M; Enjolras N; Bordet JC; Bolbos R; Brevet M; Leissinger C; Dargaud Y
    J Thromb Haemost; 2020 Mar; 18(3):584-592. PubMed ID: 31782901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.
    Tran HT; Sørensen B; Rea CJ; Bjørnsen S; Ueland T; Pripp AH; Tjønnfjord GE; Holme PA
    Haemophilia; 2014 May; 20(3):369-75. PubMed ID: 24251535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
    Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
    Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid leads to paradoxical coagulation changes during cardiac surgery: a pilot rotational thromboelastometry study.
    Sharma R; Letson HL; Smith S; Dobson GP
    J Surg Res; 2017 Sep; 217():100-112. PubMed ID: 28602219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid corrects fibrinolysis in the presence of acidemia in a swine model of severe ischemic reperfusion.
    DeBarros M; Hatch Q; Porta CR; Salgar S; Izenberg S; DuBose J; Eckert M; Martin M
    J Trauma Acute Care Surg; 2014 Mar; 76(3):625-32; discussion 632-3. PubMed ID: 24553528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
    Beckman JD; Holle LA; Wolberg AS
    J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
    Zentai C; van der Meijden PE; Braunschweig T; Hueck N; Honickel M; Spronk HM; Rossaint R; Grottke O
    Anesth Analg; 2016 Jul; 123(1):38-48. PubMed ID: 27192476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
    Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
    J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
    Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
    Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Tranexamic Acid on Coagulation and Fibrin Clot Properties in Children Undergoing Craniofacial Surgery.
    Fenger-Eriksen C; Lindholm AD; Krogh L; Hell T; Berger M; Hermann M; Fries D; Juul N; Rasmussen M; Hvas AM
    Thromb Haemost; 2020 Mar; 120(3):392-399. PubMed ID: 32016928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urokinase and consumption of α
    Longstaff C; Locke M
    J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
    Faraoni D; Rozen L; Willems A; Torres CS; Pereira LM; Demulder A; Van der Linden P
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):290-7. PubMed ID: 25806960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
    Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solulin increases clot stability in whole blood from humans and dogs with hemophilia.
    Foley JH; Petersen KU; Rea CJ; Harpell L; Powell S; Lillicrap D; Nesheim ME; Sørensen B
    Blood; 2012 Apr; 119(15):3622-8. PubMed ID: 22234684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.
    Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA
    J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.